Skip to content

Homoeopathy in hypertension

Individualized homoeopathy versus placebo in essential hypertension: a double-blind randomized controlled trial

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2014/03/004478
Enrollment
150
Registered
2014-03-18
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Essential hypertension

Interventions

Intervention1: Individualized homoeopathic medicine: Single individualized homeopathic remedy orally in centesimal or 50 millesimal potencies as appropriate. Each dose in centesimal potency was single
identical in smell, taste and appearance
dispensed in similar manner to medicine
repetition 24, 12 or 8 hourly or even oftener - total duration of such intervention 6 months

Sponsors

Mahesh Bhattacharyya Homoeopathic Medical College Hospital Government of West Bengal
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Age between 18 years and 65 years 2. Both sexes 3. Suffering from essential/primary hypertension for at least 6 months 4. History, examination, and routine investigations revealed no evidence of obvious secondary causes 5. Giving written informed consent

Exclusion criteria

Exclusion criteria: 1. Any continued anti-hypertensive therapy for at least 6 months 2. Malignant Hypertension with grave signs and symptoms as detected clinically 3. Patients suffering from isolated systolic hypertension 4. Patients with labile hypertension 5. Patients with secondary hypertension 6. Patients not strictly conforming to the criteria given by JNC-7; variation of ±10 mm Hg in SBP/DBP considerable 7. Presence of severe concomitant infectious or systemic disease(s)or organ failure, psychiatric illness, developmental or congenital anomalies, and/or complications of hypertension 8. Pregnancy, breast feeding and likelihood of pregnancy 9. History of abuse and/or dependence on drugs and/or alcohol

Design outcomes

Primary

MeasureTime frame
Change in systolic and diastolic blood pressureTimepoint: 6 months

Secondary

MeasureTime frame
Proportion of patients achieving reduction in the two groupsTimepoint: 6 months

Countries

India

Contacts

Public ContactSubhranil Saha

Central Council for Research in Homeopathy, Government of India

drsubhranilsaha@hotmail.com913532596065

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026